Advertisement

Bacterial Keratitis Preferred Practice Pattern®

Published:October 23, 2018DOI:https://doi.org/10.1016/j.ophtha.2018.10.018
      AMERICAN ACADEMY™ OF OPHTHALMOLOGY
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scottish Intercollegiate Guidelines Network (SIGN)
        SIGN 50: a guideline developer's handbook.
        SIGN, Edinburgh2015 (SIGN publication no. 50). [November 2015].
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • GRADE Working Group
        Organizations that have endorsed or that are using GRADE.
        http://www.gradeworkinggroup.org/
        Date accessed: September 19, 2018
        • McLeod SD
        • Kolahdouz-Isfahani A
        • Rostamian K
        • Flowers CW
        • Lee PP
        • McDonnell PJ
        The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis.
        Ophthalmology. 1996; 103: 23-28
        • Park J
        • Lee KM
        • Zhou H
        • et al.
        Community practice patterns for bacterial corneal ulcer evaluation and treatment.
        Eye Contact Lens. 2015; 41: 12-18
        • Wilhelmus K
        • Liesegang TJ
        • Osato MS
        • Jones DB
        Laboratory Diagnosis of Ocular Infections.
        American Society for Microbiology, Washington, DC1994
        • Jeng BH
        • Gritz DC
        • Kumar AB
        • et al.
        Epidemiology of ulcerative keratitis in Northern California.
        Arch Ophthalmol. 2010; 128: 1022-1028
        • Joslin CE
        • Tu EY
        • McMahon TT
        • Passaro DJ
        • Stayner LT
        • Sugar J
        Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak.
        Am J Ophthalmol. 2006; 142: 212-217
        • Yildiz EH
        • Airiani S
        • Hammersmith KM
        • et al.
        Trends in contact lens-related corneal ulcers at a tertiary referral center.
        Cornea. 2012; 31: 1097-1102
        • Jin H
        • Parker WT
        • Law NW
        • et al.
        Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital.
        Br J Ophthalmol. 2017; 101: 1483-1487
        • Henry CR
        • Flynn Jr., HW
        • Miller D
        • Forster RK
        • Alfonso EC
        Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes.
        Ophthalmology. 2012; 119: 2443-2449
        • Sand D
        • She R
        • Shulman IA
        • Chen DS
        • Schur M
        • Hsu HY
        Microbial keratitis in Los Angeles: the Doheny Eye Institute and the Los Angeles county hospital experience.
        Ophthalmology. 2015; 122: 918-924
        • Mah-Sadorra JH
        • Yavuz SG
        • Najjar DM
        • Laibson PR
        • Rapuano CJ
        • Cohen EJ
        Trends in contact lens-related corneal ulcers.
        Cornea. 2005; 24: 51-58
        • Green M
        • Apel A
        • Stapleton F
        Risk factors and causative organisms in microbial keratitis.
        Cornea. 2008; 27: 22-27
        • Alexandrakis G
        • Alfonso EC
        • Miller D
        Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
        Ophthalmology. 2000; 107: 1497-1502
        • Keay L
        • Edwards K
        • Naduvilath T
        • et al.
        Microbial keratitis: predisposing factors and morbidity.
        Ophthalmology. 2006; 113: 109-116
        • Estopinal CB
        • Ewald MD
        Geographic disparities in the etiology of bacterial and fungal keratitis in the United States of America.
        Semin Ophthalmol. 2016; 31: 345-352
        • Pandita A
        • Murphy C
        Microbial keratitis in Waikato, New Zealand.
        Clin Exp Ophthalmol. 2011; 39: 393-397
        • Orlans HO
        • Hornby SJ
        • Bowler IC
        In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.
        Eye (Lond). 2011; 25: 489-493
        • Passos RM
        • Cariello AJ
        • Yu MC
        • Hofling-Lima AL
        Microbial keratitis in the elderly: a 32-year review.
        Arq Bras Oftalmol. 2010; 73: 315-319
        • Zhang C
        • Liang Y
        • Deng S
        • Wang Z
        • Li R
        • Sun X
        Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004.
        Clin Ophthalmol. 2008; 2: 575-579
        • Pakzad-Vaezi K
        • Levasseur SD
        • Schendel S
        • et al.
        The corneal ulcer one-touch study: a simplified microbiological specimen collection method.
        Am J Ophthalmol. 2015; 159 (e31.): 37-43
        • Ahn M
        • Yoon KC
        • Ryu SK
        • Cho NC
        • You IC
        Clinical aspects and prognosis of mixed microbial (bacterial and fungal) keratitis.
        Cornea. 2011; 30: 409-413
        • Tu EY
        • Joslin CE
        • Nijm LM
        • Feder RS
        • Jain S
        • Shoff ME
        Polymicrobial keratitis: Acanthamoeba and infectious crystalline keratopathy.
        Am J Ophthalmol. 2009; 148 (e12.): 13-19
        • Ray KJ
        • Prajna L
        • Srinivasan M
        • et al.
        Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
        JAMA Ophthalmol. 2013; 131: 310-313
        • Ibrahim YW
        • Boase DL
        • Cree IA
        Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study.
        Br J Ophthalmol. 2009; 93: 1319-1324
        • Cruciani F
        • Cuozzo G
        • Di Pillo S
        • Cavallaro M
        Predisposing factors, clinical and microbiological aspects of bacterial keratitis: a clinical study.
        Clin Ter. 2009; 160: 207-210
        • American Academy of Ophthalmology Refractive Management/Intervention Panel
        Preferred Practice Pattern®. Refractive Errors & Refractive Surgery.
        American Academy of Ophthalmology, San Francisco, CA2017
        • Cheung N
        • Nagra P
        • Hammersmith K
        Emerging trends in contact lens-related infections.
        Curr Opin Ophthalmol. 2016; 27: 327-332
        • Lim CH
        • Carnt NA
        • Farook M
        • et al.
        Risk factors for contact lens-related microbial keratitis in Singapore.
        Eye (Lond). 2016; 30: 447-455
        • Robertson DM
        The effects of silicone hydrogel lens wear on the corneal epithelium and risk for microbial keratitis.
        Eye Contact Lens. 2013; 39: 67-72
        • Saini A
        • Rapuano CJ
        • Laibson PR
        • Cohen EJ
        • Hammersmith KM
        Episodes of microbial keratitis with therapeutic silicone hydrogel bandage soft contact lenses.
        Eye Contact Lens. 2013; 39: 324-328
        • Dhiman R
        • Singh A
        • Tandon R
        • Vanathi M
        Contact lens induced Pseudomonas keratitis following descemet stripping automated endothelial keratoplasty.
        Cont Lens Anterior Eye. 2015; 38: 379-381
        • Cope JR
        • Collier SA
        • Srinivasan K
        • et al.
        Contact Lens–Related Corneal Infections — United States, 2005–2015.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 817-820
        • Stapleton F
        • Naduvilath T
        • Keay L
        • et al.
        Risk factors and causative organisms in microbial keratitis in daily disposable contact lens wear.
        PLoS One. 2017; 12e0181343
        • Rossetto JD
        • Cavuoto KM
        • Osigian CJ
        • et al.
        Paediatric infectious keratitis: a case series of 107 children presenting to a tertiary referral centre.
        Br J Ophthalmol. 2017; 101: 1488-1492
        • Keay L
        • Stapleton F
        • Schein O
        Epidemiology of contact lens-related inflammation and microbial keratitis: a 20-year perspective.
        Eye Contact Lens. 2007; 33 (discussion 362-343.): 346-353
        • Dart JK
        • Radford CF
        • Minassian D
        • Verma S
        • Stapleton F
        Risk factors for microbial keratitis with contemporary contact lenses: a case-control study.
        Ophthalmology. 2008; 115: 1647-1654
        • Stapleton F
        • Keay L
        • Edwards K
        • et al.
        The incidence of contact lens-related microbial keratitis in Australia.
        Ophthalmology. 2008; 115: 1655-1662
        • Sauer A
        • Meyer N
        • Bourcier T
        Risk factors for contact lens-related microbial keratitis: a case-control multicenter study.
        Eye Contact Lens. 2016; 42: 158-162
        • Stapleton F
        • Edwards K
        • Keay L
        • et al.
        Risk factors for moderate and severe microbial keratitis in daily wear contact lens users.
        Ophthalmology. 2012; 119: 1516-1521
        • Araki-Sasaki K
        • Nishi I
        • Yonemura N
        • et al.
        Characteristics of Pseudomonas corneal infection related to orthokeratology.
        Cornea. 2005; 24: 861-863
        • Hsiao CH
        • Lin HC
        • Chen YF
        • et al.
        Infectious keratitis related to overnight orthokeratology.
        Cornea. 2005; 24: 783-788
        • Tseng CH
        • Fong CF
        • Chen WL
        • Hou YC
        • Wang IJ
        • Hu FR
        Overnight orthokeratology-associated microbial keratitis.
        Cornea. 2005; 24: 778-782
        • Wilhelmus KR
        Acanthamoeba keratitis during orthokeratology.
        Cornea. 2005; 24: 864-866
        • Yepes N
        • Lee SB
        • Hill V
        • Ashenhurst M
        • Saunders PP
        • Slomovic AR
        Infectious keratitis after overnight orthokeratology in Canada.
        Cornea. 2005; 24: 857-860
        • Van Meter WS
        • Musch DC
        • Jacobs DS
        • Kaufman SC
        • Reinhart WJ
        • Udell IJ
        Safety of overnight orthokeratology for myopia: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2008; 115: 2301-2313
        • Lee YS
        • Tan HY
        • Yeh LK
        • et al.
        Pediatric microbial keratitis in Taiwan: clinical and microbiological profiles, 1998-2002 versus 2008-2012.
        Am J Ophthalmol. 2014; 157: 1090-1096
        • Young AL
        • Leung KS
        • Tsim N
        • Hui M
        • Jhanji V
        Risk factors, microbiological profile, and treatment outcomes of pediatric microbial keratitis in a tertiary care hospital in Hong Kong.
        Am J Ophthalmol. 2013; 156 (e1042.): 1040-1044
        • Bullimore MA
        • Sinnott LT
        • Jones-Jordan LA
        The risk of microbial keratitis with overnight corneal reshaping lenses.
        Optom Vis Sci. 2013; 90: 937-944
        • Kam KW
        • Yung W
        • Li GKH
        • Chen LJ
        • Young AL
        Infectious keratitis and orthokeratology lens use: a systematic review.
        Infection. 2017; 45: 727-735
        • Wu YT
        • Willcox M
        • Zhu H
        • Stapleton F
        Contact lens hygiene compliance and lens case contamination: A review.
        Cont Lens Anterior Eye. 2015; 38: 307-316
        • Zimmerman AB
        • Richdale K
        • Mitchell GL
        • et al.
        Water Exposure is a Common Risk Behavior Among Soft and Gas-Permeable Contact Lens Wearers.
        Cornea. 2017; 36: 995-1001
        • Cope JR
        • Collier SA
        • Schein OD
        • et al.
        Acanthamoeba keratitis among rigid gas permeable contact lens wearers in the United States, 2005 through 2011.
        Ophthalmology. 2016; 123: 1435-1441
        • Ji YW
        • Cho YJ
        • Lee CH
        • et al.
        Comparison of surface roughness and bacterial adhesion between cosmetic contact lenses and conventional contact lenses.
        Eye Contact Lens. 2015; 41: 25-33
        • Abdelkader A
        Cosmetic soft contact lens associated ulcerative keratitis in southern Saudi Arabia.
        Middle East Afr J Ophthalmol. 2014; 21: 232-235
        • Singh S
        • Satani D
        • Patel A
        • Vhankade R
        Colored cosmetic contact lenses: an unsafe trend in the younger generation.
        Cornea. 2012; 31: 777-779
        • Young G
        • Young AG
        • Lakkis C
        Review of complications associated with contact lenses from unregulated sources of supply.
        Eye Contact Lens. 2014; 40: 58-64
        • Steinemann TL
        • Fletcher M
        • Bonny AE
        • et al.
        Over-the-counter decorative contact lenses: Cosmetic or Medical Devices? A Case Series.
        Eye Contact Lens. 2005; 31: 194-200
        • Steinemann TL
        • Pinninti U
        • Szczotka LB
        • Eiferman RA
        • Price Jr., FW
        Ocular complications associated with the use of cosmetic contact lenses from unlicensed vendors.
        Eye Contact Lens. 2003; 29: 196-200
        • Forister JF
        • Forister EF
        • Yeung KK
        • et al.
        Prevalence of contact lens-related complications: UCLA contact lens study.
        Eye Contact Lens. 2009; 35: 176-180
        • Chidambaram JD
        • Venkatesh Prajna N
        • Srikanthi P
        • et al.
        Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India.
        Ophthalmic Epidemiol. 2018; 25: 297-305
        • Kang BS
        • Kim MK
        • Wee WR
        • Oh JY
        Infectious keratitis in limbal stem cell deficiency: Stevens-Johnson syndrome versus chemical burn.
        Cornea. 2016; 35: 51-55
        • Ortega-Usobiaga J
        • Llovet-Osuna F
        • Djodeyre MR
        • Llovet-Rausell A
        • Beltran J
        • Baviera J
        Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment.
        J Cataract Refract Surg. 2015; 41: 1210-1216
        • Duignan ES
        • Farrell S
        • Treacy MP
        • et al.
        Corneal inlay implantation complicated by infectious keratitis.
        Br J Ophthalmol. 2016; 100: 269-273
        • Lee BJ
        • Smith SD
        • Jeng BH
        Suture-related corneal infections after clear corneal cataract surgery.
        J Cataract Refract Surg. 2009; 35: 939-942
        • Constantinou M
        • Jhanji V
        • Vajpayee RB
        Clinical and microbiological profile of post-penetrating keratoplasty infectious keratitis in failed and clear grafts.
        Am J Ophthalmol. 2013; 155: 233-237
        • Sung MS
        • Choi W
        • You IC
        • Yoon KC
        Factors affecting treatment outcome of graft infection following penetrating keratoplasty.
        Korean J Ophthalmol. 2015; 29: 301-308
        • Kim MJ
        • Yu F
        • Aldave AJ
        Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes.
        Ophthalmology. 2013; 120: 2209-2216
        • Davies E
        • Chodosh J
        Infections after keratoprosthesis.
        Curr Opin Ophthalmol. 2016; 27: 373-377
        • Siganos CS
        • Solomon A
        • Frucht-Pery J
        Microbial findings in suture erosion after penetrating keratoplasty.
        Ophthalmology. 1997; 104: 513-516
        • Li G
        • Guo J
        • Liu R
        • et al.
        Lacrimal duct occlusion is associated with infectious keratitis.
        Int J Med Sci. 2016; 13: 800-805
        • Wang B
        • Yang S
        • Zhai HL
        • et al.
        A comparative study of risk factors for corneal infection in diabetic and non-diabetic patients.
        Int J Ophthalmol. 2018; 11: 43-47
        • Parkin B
        • Turner A
        • Moore E
        • Cook S
        Bacterial keratitis in the critically ill.
        Br J Ophthalmol. 1997; 81: 1060-1063
        • McClintic SM
        • Prajna NV
        • Srinivasan M
        • et al.
        Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
        Invest Ophthalmol Vis Sci. 2014; 55: 2935-2940
        • Lim NC
        • Lim DK
        • Ray M
        Polymicrobial versus monomicrobial keratitis: a retrospective comparative study.
        Eye Contact Lens. 2013; 39: 348-354
        • Wallace DK
        • Morse CL
        • Melia M
        • et al.
        Pediatric eye evaluations Preferred Practice Pattern®: I. Vision screening in the primary care and community setting; II. Comprehensive ophthalmic examination.
        Ophthalmology. 2018; 125 (or): P184-P227
        • Feder RS
        • Olsen TW
        • Prum Jr., BE
        • et al.
        Comprehensive adult medical eye evaluation Preferred Practice Pattern® guidelines.
        Ophthalmology. 2016; 123 (or): P209-236
        • Stein RM
        • Clinch TE
        • Cohen EJ
        • Genvert GI
        • Arentsen JJ
        • Laibson PR
        Infected vs sterile corneal infiltrates in contact lens wearers.
        Am J Ophthalmol. 1988; 105: 632-636
        • Dalmon C
        • Porco TC
        • Lietman TM
        • et al.
        The clinical differentiation of bacterial and fungal keratitis: a photographic survey.
        Invest Ophthalmol Vis Sci. 2012; 53: 1787-1791
        • Rudolph T
        • Welinder-Olsson C
        • Lind-Brandberg L
        • Stenevi U
        16S rDNA PCR analysis of infectious keratitis: a case series.
        Acta Ophthalmol Scand. 2004; 82: 463-467
        • Butler TK
        • Spencer NA
        • Chan CC
        • Singh Gilhotra J
        • McClellan K
        Infective keratitis in older patients: a 4 year review, 1998-2002.
        Br J Ophthalmol. 2005; 89: 591-596
        • Itahashi M
        • Higaki S
        • Fukuda M
        • Shimomura Y
        Detection and quantification of pathogenic bacteria and fungi using real-time polymerase chain reaction by cycling probe in patients with corneal ulcer.
        Arch Ophthalmol. 2010; 128: 535-540
        • Kim E
        • Chidambaram JD
        • Srinivasan M
        • et al.
        Prospective comparison of microbial culture and polymerase chain reaction in the diagnosis of corneal ulcer.
        Am J Ophthalmol. 2008; 146: 714-723
        • Panda A
        • Pal Singh T
        • Satpathy G
        • Wadhwani M
        • Monika M
        Comparison of polymerase chain reaction and standard microbiological techniques in presumed bacterial corneal ulcers.
        Int Ophthalmol. 2015; 35: 159-165
        • Labetoulle M
        • Frau E
        • Offret H
        • Nordmann P
        • Naas T
        Non-preserved 1% lidocaine solution has less antibacterial properties than currently available anaesthetic eye-drops.
        Curr Eye Res. 2002; 25: 91-97
        • Waxman E
        • Chechelnitsky M
        • Mannis MJ
        • Schwab IR
        Single culture media in infectious keratitis.
        Cornea. 1999; 18: 257-261
        • Kaye SB
        • Rao PG
        • Smith G
        • et al.
        Simplifying collection of corneal specimens in cases of suspected bacterial keratitis.
        J Clin Microbiol. 2003; 41: 3192-3197
        • McLeod SD
        • Kumar A
        • Cevallos V
        • Srinivasan M
        • Whitcher JP
        Reliability of transport medium in the laboratory evaluation of corneal ulcers.
        Am J Ophthalmol. 2005; 140: 1027-1031
        • Bhadange Y
        • Sharma S
        • Das S
        • Sahu SK
        Role of liquid culture media in the laboratory diagnosis of microbial keratitis.
        Am J Ophthalmol. 2013; 156: 745-751
        • Marangon FB
        • Miller D
        • Alfonso EC
        Impact of prior therapy on the recovery and frequency of corneal pathogens.
        Cornea. 2004; 23: 158-164
        • Younger JR
        • Johnson RD
        • Holland GN
        • et al.
        Microbiologic and histopathologic assessment of corneal biopsies in the evaluation of microbial keratitis.
        Am J Ophthalmol. 2012; 154: 512-519
        • Newton C
        • Moore MB
        • Kaufman HE
        Corneal biopsy in chronic keratitis.
        Arch Ophthalmol. 1987; 105: 577-578
        • Alexandrakis G
        • Haimovici R
        • Miller D
        • Alfonso EC
        Corneal biopsy in the management of progressive microbial keratitis.
        Am J Ophthalmol. 2000; 129: 571-576
        • Hwang DG
        Lamellar flap corneal biopsy.
        Ophthalmic Surg. 1993; 24: 512-515
        • Hau SC
        • Dart JK
        • Vesaluoma M
        • et al.
        Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy.
        Br J Ophthalmol. 2010; 94: 982-987
        • Kaufman SC
        • Musch DC
        • Belin MW
        • et al.
        Confocal microscopy: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2004; 111: 396-406
        • Labbe A
        • Khammari C
        • Dupas B
        • et al.
        Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis.
        Ocul Surf. 2009; 7: 41-52
        • Tu EY
        • Joslin CE
        • Sugar J
        • Booton GC
        • Shoff ME
        • Fuerst PA
        The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis.
        Cornea. 2008; 27: 764-772
        • Centers for Disease Control and Prevention
        Update: Fusarium keratitis–United States, 2005-2006.
        MMWR Morb Mortal Wkly Rep. 2006; 55: 563-564
        • Centers for Disease Control and Prevention
        Acanthamoeba keratitis multiple states, 2005-2007.
        MMWR Morb Mortal Wkly Rep. 2007; 56: 532-534
        • Alfonso EC
        • Cantu-Dibildox J
        • Munir WM
        • et al.
        Insurgence of Fusarium keratitis associated with contact lens wear.
        Arch Ophthalmol. 2006; 124: 941-947
        • Bernal MD
        • Acharya NR
        • Lietman TM
        • Strauss EC
        • McLeod SD
        • Hwang DG
        Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco.
        Arch Ophthalmol. 2006; 124: 1051-1053
        • Chang DC
        • Grant GB
        • O'Donnell K
        • et al.
        Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution.
        JAMA. 2006; 296: 953-963
        • Joslin CE
        • Tu EY
        • Shoff ME
        • et al.
        The association of contact lens solution use and acanthamoeba keratitis.
        Am J Ophthalmol. 2007; 144: 169-180
        • Khor WB
        • Aung T
        • Saw SM
        • et al.
        An outbreak of Fusarium keratitis associated with contact lens wear in Singapore.
        JAMA. 2006; 295: 2867-2873
        • Margolis TP
        • Whitcher JP
        Fusarium–A new culprit in the contact lens case.
        JAMA. 2006; 296: 985-987
        • Saw SM
        • Ooi PL
        • Tan DT
        • et al.
        Risk factors for contact lens-related Fusarium keratitis: a case-control study in Singapore.
        Arch Ophthalmol. 2007; 125: 611-617
        • Thebpatiphat N
        • Hammersmith KM
        • Rocha FN
        • et al.
        Acanthamoeba keratitis: a parasite on the rise.
        Cornea. 2007; 26: 701-706
        • Mascarenhas J
        • Lalitha P
        • Prajna NV
        • et al.
        Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features.
        Am J Ophthalmol. 2014; 157: 56-62
        • Prabriputaloong T
        • Margolis TP
        • Lietman TM
        • Wong IG
        • Mather R
        • Gritz DC
        Atopic disease and herpes simplex eye disease: a population-based case-control study.
        Am J Ophthalmol. 2006; 142: 745-749
        • U.S. Food and Drug Administration
        Advice for patients with soft contact lenses: new information on risk of serious fungal infection.
        (Updated April 21, 2006.)
        • Hwang DG
        Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.
        Surv Ophthalmol. 2004; 49: S79-83
        • American Academy of Pediatrics, Committee on Sports Medicine Fitness; American Academy of Ophthalmology, Eye Health Public Information Task Force
        Protective eyewear for young athletes.
        Ophthalmology. 2004; 111: 600-603
        • Mascarenhas J
        • Srinivasan M
        • Chen M
        • et al.
        Differentiation of etiologic agents of bacterial keratitis from presentation characteristics.
        Int Ophthalmol. 2012; 32: 531-538
        • Upadhyay MP
        • Karmacharya PC
        • Koirala S
        • et al.
        The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal.
        Br J Ophthalmol. 2001; 85: 388-392
        • Hanet MS
        • Jamart J
        • Chaves AP
        Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies.
        Can J Ophthalmol. 2012; 47: 493-499
        • Bajgrowicz M
        • Phan CM
        • Subbaraman LN
        • Jones L
        Release of ciprofloxacin and moxifloxacin from daily disposable contact lenses from an in vitro eye model.
        Invest Ophthalmol Vis Sci. 2015; 56: 2234-2242
        • Phinney RB
        • Schwartz SD
        • Lee DA
        • Mondino BJ
        Collagen-shield delivery of gentamicin and vancomycin.
        Arch Ophthalmol. 1988; 106: 1599-1604
        • Mondino BJ
        Collagen shields.
        Am J Ophthalmol. 1991; 112: 587-590
        • Lee BL
        • Matoba AY
        • Osato MS
        • Robinson NM
        The solubility of antibiotic and corticosteroid combinations.
        Am J Ophthalmol. 1992; 114: 212-215
        • Lalitha P
        • Srinivasan M
        • Manikandan P
        • et al.
        Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
        Clin Infect Dis. 2012; 54: 1381-1387
        • Constantinou M
        • Daniell M
        • Snibson GR
        • Vu HT
        • Taylor HR
        Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
        Ophthalmology. 2007; 114: 1622-1629
        • Khokhar S
        • Sindhu N
        • Mirdha BR
        Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
        Infection. 2000; 28: 149-152
        • Gangopadhyay N
        • Daniell M
        • Weih L
        • Taylor HR
        Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
        Br J Ophthalmol. 2000; 84: 378-384
        • Sharma N
        • Arora T
        • Jain V
        • et al.
        Gatifloxacin 0.3% versus fortified tobramycin-cefazolin in treating nonperforated bacterial corneal ulcers: randomized, controlled trial.
        Cornea. 2016; 35: 56-61
        • Sharma N
        • Goel M
        • Bansal S
        • et al.
        Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
        Ophthalmology. 2013; 120: 1173-1178
        • McDonald EM
        • Ram FS
        • Patel DV
        • McGhee CN
        Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
        Br J Ophthalmol. 2014; 98: 1470-1477
        • U.S. Food and Drug Administration, Center for Drug Evaluation and Research
        Ciloxan® (ciprofloxacin HCL ophthalmic solution), 0.3% as Base. NDA 19-992/S-020. 2006:4-5.
        • U.S. Food and Drug Administration, Center for Drug Evaluation and Research
        Ocuflox® (ofloxacin ophthalmic solution) 0.3% sterile. NDA 19-921/S-008. 1999:7.
        • U.S. Food and Drug Administration, Center for Drug Evaluation and Research
        Iquix® (levofloxacin ophthalmic solution) 1.5%. NDA 21-571.
        • Wilhelmus KR
        • Abshire RL
        • Schlech BA
        Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.
        Arch Ophthalmol. 2003; 121: 1229-1233
        • Goldstein MH
        • Kowalski RP
        • Gordon YJ
        Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
        Ophthalmology. 1999; 106: 1313-1318
        • Garg P
        • Sharma S
        • Rao GN
        Ciprofloxacin-resistant Pseudomonas keratitis.
        Ophthalmology. 1999; 106: 1319-1323
        • Lee J
        • Choi S
        Risk factors for fluoroquinolone resistance in ocular cultures.
        Korean J Ophthalmol. 2015; 29: 7-13
        • Asbell PA
        • Sanfilippo CM
        • Pillar CM
        • DeCory HH
        • Sahm DF
        • Morris TW
        Antibiotic resistance among ocular pathogens in the United States: five-year results rrom the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
        JAMA Ophthalmol. 2015; 133: 1445-1454
        • Chang VS
        • Dhaliwal DK
        • Raju L
        • Kowalski RP
        Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-year review.
        Cornea. 2015; 34: 698-703
        • Peng MY
        • Cevallos V
        • McLeod SD
        • Lietman TM
        • Rose-Nussbaumer J
        Bacterial keratitis: isolated organisms and antibiotic resistance patterns in San Francisco.
        Cornea. 2018; 37: 84-87
        • Kowalski RP
        • Dhaliwal DK
        • Karenchak LM
        • et al.
        Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
        Am J Ophthalmol. 2003; 136: 500-505
        • Parmar P
        • Salman A
        • Kalavathy CM
        • et al.
        Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
        Am J Ophthalmol. 2006; 141: 282-286
        • Chawla B
        • Agarwal P
        • Tandon R
        • et al.
        In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
        Eur J Ophthalmol. 2010; 20: 300-305
        • Hsu HY
        • Nacke R
        • Song JC
        • Yoo SH
        • Alfonso EC
        • Israel HA
        Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states.
        Eye Contact Lens. 2010; 36: 195-200
        • Shah VM
        • Tandon R
        • Satpathy G
        • et al.
        Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
        Cornea. 2010; 29: 751-757
        • Oldenburg CE
        • Lalitha P
        • Srinivasan M
        • et al.
        Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
        Ophthalmic Epidemiol. 2013; 20: 155-158
        • Kowalski RP
        • Kowalski TA
        • Shanks RM
        • Romanowski EG
        • Karenchak LM
        • Mah FS
        In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
        Cornea. 2013; 32: 830-834
        • Morris TW
        • Gearinger LS
        • Usner DW
        • et al.
        Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes.
        Clin Ophthalmol. 2011; 5: 1359-1367
        • Sanders ME
        • Norcross EW
        • Moore 3rd, QC
        • Shafiee A
        • Marquart ME
        Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
        Cornea. 2009; 28: 1055-1060
        • Sanders ME
        • Moore 3rd, QC
        • Norcross EW
        • Shafiee A
        • Marquart ME
        Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
        J Ocul Pharmacol Ther. 2010; 26: 193-198
        • Sanders ME
        • Moore 3rd, QC
        • Norcross EW
        • et al.
        Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
        Cornea. 2011; 30: 83-90
        • Miller D
        • Chang JS
        • Flynn HW
        • Alfonso EC
        Comparative in vitro susceptibility of besifloxacin and seven comparators against ciprofloxacin- and methicillin-susceptible/nonsusceptible staphylococci.
        J Ocul Pharmacol Ther. 2013; 29: 339-344
        • Mah FS
        • Sanfilippo CM
        Besifloxacin: efficacy and safety in treatment and prevention of ocular bacterial infections.
        Ophthalmol Ther. 2016; 5: 1-20
        • American Academy of Ophthalmology
        Clinical Statement. Verifying the source of compounded bevacizumab for intravitreal injections.
        • John T
        • Velotta E
        Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications.
        Cornea. 2005; 24: 245-255
        • Ko J
        • Kim SK
        • Yong DE
        • Kim TI
        • Kim EK
        Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review.
        Medicine (Baltimore). 2017; 96e9356
        • Marangon FB
        • Miller D
        • Muallem MS
        • Romano AC
        • Alfonso EC
        Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
        Am J Ophthalmol. 2004; 137: 453-458
        • Ni N
        • Nam EM
        • Hammersmith KM
        • et al.
        Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania.
        Cornea. 2015; 34: 296-302
        • Hernandez-Camarena JC
        • Graue-Hernandez EO
        • Ortiz-Casas M
        • et al.
        Trends in microbiological and antibiotic sensitivity patterns in infectious keratitis: 10-year experience in Mexico City.
        Cornea. 2015; 34: 778-785
        • Lichtinger A
        • Yeung SN
        • Kim P
        • et al.
        Shifting trends in bacterial keratitis in Toronto: an 11-year review.
        Ophthalmology. 2012; 119: 1785-1790
        • Mah FS
        • Davidson R
        • Holland EJ
        • et al.
        Current knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureus.
        J Cataract Refract Surg. 2014; 40: 1894-1908
        • Vola ME
        • Moriyama AS
        • Lisboa R
        • et al.
        Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections.
        Arq Bras Oftalmol. 2013; 76: 350-353
        • Solomon R
        • Donnenfeld ED
        • Perry HD
        • et al.
        Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
        Am J Ophthalmol. 2007; 143: 629-634
        • Asbell PA
        • Colby KA
        • Deng S
        • et al.
        Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
        Am J Ophthalmol. 2008; 145: 951-958
        • Saillard J
        • Spiesser-Robelet L
        • Gohier P
        • Briot T
        Bacterial keratitis treated by strengthened antibiotic eye drops: An 18 months review of clinical cases and antibiotic susceptibilities.
        Ann Pharm Fr. 2018; 76: 107-113
        • Tam ALC
        • Cote E
        • Saldanha M
        • Lichtinger A
        • Slomovic AR
        Bacterial keratitis in Toronto: A 16-year review of the microorganisms isolated and the resistance patterns observed.
        Cornea. 2017; 36: 1528-1534
        • Vazirani J
        • Wurity S
        • Ali MH
        Multidrug-resistant Pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes.
        Ophthalmology. 2015; 122: 2110-2114
        • Jain R
        • Murthy SI
        • Motukupally SR
        Clinical outcomes of corneal graft infections caused by multi-drug resistant Pseudomonas aeruginosa.
        Cornea. 2014; 33: 22-26
        • Jain R
        • Murthy SI
        • Motukupally SR
        • Jain M
        Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.
        Cornea. 2014; 33: 923-927
        • Inoue H
        • Suzuki T
        • Inoue T
        • et al.
        Clinical characteristics and bacteriological profile of Moraxella keratitis.
        Cornea. 2015; 34: 1105-1109
        • Kaye R
        • Kaye A
        • Sueke H
        • et al.
        Recurrent bacterial keratitis.
        Invest Ophthalmol Vis Sci. 2013; 54: 4136-4139
        • Centers for Disease Control and Prevention
        Sexually transmitted diseases treatment guidelines, 2010.
        MMWR Morb Mortal Wkly Rep. 2010; 59: 53
        • Wilhelmus KR
        Indecision about corticosteroids for bacterial keratitis: an evidence-based update.
        Ophthalmology. 2002; 109: 835-842
        • Suwan-apichon O
        • Reyes JM
        • Herretes S
        • Vedula SS
        • Chuck RS
        Topical corticosteroids as adjunctive therapy for bacterial keratitis.
        Cochrane Database of Syst Rev. 2007; CD005430
        • Blair J
        • Hodge W
        • Al-Ghamdi S
        • et al.
        Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial.
        Can J Ophthalmol. 2011; 46: 40-45
        • Herretes S
        • Wang X
        • Reyes JM
        Topical corticosteroids as adjunctive therapy for bacterial keratitis.
        Cochrane Database Syst Rev. 2014; CD005430
        • Srinivasan M
        • Mascarenhas J
        • Rajaraman R
        • Steroids for Corneal Ulcers Trial Group
        • et al.
        Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
        Arch Ophthalmol. 2012; 130: 143-150
        • Lalitha P
        • Srinivasan M
        • Rajaraman R
        • et al.
        Nocardia keratitis: clinical course and effect of corticosteroids.
        Am J Ophthalmol. 2012; 154: 934-939
        • Srinivasan M
        • Mascarenhas J
        • Rajaraman R
        • et al.
        The Steroids for Corneal Ulcers Trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
        Am J Ophthalmol. 2014; 157 (e323.): 327-333
        • Ray KJ
        • Srinivasan M
        • Mascarenhas J
        • et al.
        Early addition of topical corticosteroids in the treatment of bacterial keratitis.
        JAMA Ophthalmol. 2014; 132: 737-741
        • Tallab RT
        • Stone DU
        Corticosteroids as a therapy for bacterial keratitis: an evidence-based review of ‘who, when and why’.
        Br J Ophthalmol. 2016; 100: 731-735
        • Miedziak AI
        • Miller MR
        • Rapuano CJ
        • Laibson PR
        • Cohen EJ
        Risk factors in microbial keratitis leading to penetrating keratoplasty.
        Ophthalmology. 1999; 106 (discussion 1171.): 1166-1170
        • Ni N
        • Srinivasan M
        • McLeod SD
        • Acharya NR
        • Lietman TM
        • Rose-Nussbaumer J
        Use of adjunctive topical corticosteroids in bacterial keratitis.
        Curr Opin Ophthalmol. 2016; 27: 353-357
        • Maki S
        • Hou JH
        • Maltry AC
        Infectious crystalline keratopathy.
        • American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee
        Basic and Clinical Science Course. External Disease and Cornea: Section 8, 2017-2018.
        American Academy of Ophthalmology, San Francisco, CA2017: 271
        • McElvanney AM
        Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature.
        Eye Contact Lens. 2003; 29: 258-261
        • Ralph RA
        Tetracyclines and the treatment of corneal stromal ulceration: a review.
        Cornea. 2000; 19: 274-277
        • Hoffmann S
        • Szentmary N
        • Seitz B
        Amniotic membrane transplantation for the treatment of infectious ulcerative keratitis before elective penetrating keratoplasty.
        Cornea. 2013; 32: 1321-1325
        • Altay Y
        • Tamer S
        • Burcu A
        • Balta O
        Amniotic membrane transplantation in bacterial and herpetic stromal keratitis.
        Turk J Med Sci. 2016; 46: 457-462
        • Tabatabaei SA
        • Soleimani M
        • Behrouz MJ
        • Torkashvand A
        • Anvari P
        • Yaseri M
        A randomized clinical trial to evaluate the usefulness of amniotic membrane transplantation in bacterial keratitis healing.
        Ocul Surf. 2017; 15: 218-226
        • Kheirkhah A
        • Tabatabaei A
        • Zavareh MK
        • Khodabandeh A
        • Mohammadpour M
        • Raju VK
        A controlled study of amniotic membrane transplantation for acute Pseudomonas keratitis.
        Can J Ophthalmol. 2012; 47: 305-311
        • Abdulhalim BE
        • Wagih MM
        • Gad AA
        • Boghdadi G
        • Nagy RR
        Amniotic membrane graft to conjunctival flap in treatment of non-viral resistant infectious keratitis: a randomised clinical study.
        Br J Ophthalmol. 2015; 99: 59-63
        • Prajna NV
        • Srinivasan M
        • Lalitha P
        • et al.
        Differences in clinical outcomes in keratitis due to fungus and bacteria.
        JAMA Ophthalmol. 2013; 131: 1088-1089
        • Isenberg SJ
        • Apt L
        • Valenton M
        • et al.
        Prospective, randomized clinical trial of povidone-iodine 1.25% solution versus topical antibiotics for treatment of bacterial keratitis.
        Am J Ophthalmol. 2017; 176: 244-253
        • Bamdad S
        • Malekhosseini H
        • Khosravi A
        Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers.
        Cornea. 2015; 34: 402-406
        • Chan TC
        • Agarwal T
        • Vajpayee RB
        • Jhanji V
        Cross-linking for microbial keratitis.
        Curr Opin Ophthalmol. 2016; 27: 348-352
        • Sorkhabi R
        • Sedgipoor M
        • Mahdavifard A
        Collagen cross-linking for resistant corneal ulcer.
        Int Ophthalmol. 2013; 33: 61-66
        • Skaat A
        • Zadok D
        • Goldich Y
        • et al.
        Riboflavin/UVA photochemical therapy for severe infectious keratitis.
        Eur J Ophthalmol. 2014; 24: 21-28
        • Alio JL
        • Abbouda A
        • Valle DD
        • Del Castillo JM
        • Fernandez JA
        Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases.
        J Ophthalmic Inflamm Infect. 2013; 3: 47
        • Price MO
        • Price Jr., FW
        Corneal cross-linking in the treatment of corneal ulcers.
        Curr Opin Ophthalmol. 2016; 27: 250-255
        • Makdoumi K
        • Mortensen J
        • Sorkhabi O
        • Malmvall BE
        • Crafoord S
        UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.
        Graefes Arch Clin Exp Ophthalmol. 2012; 250: 95-102
        • Price MO
        • Tenkman LR
        • Schrier A
        • Fairchild KM
        • Trokel SL
        • Price Jr., FW
        Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology.
        J Refract Surg. 2012; 28: 706-713
        • Papaioannou L
        • Miligkos M
        • Papathanassiou M
        Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis.
        Cornea. 2016; 35: 62-71
        • Austin A
        • Schallhorn J
        • Geske M
        • Mannis M
        • Lietman T
        • Rose-Nussbaumer J
        Empirical treatment of bacterial keratitis: an international survey of corneal specialists.
        BMJ Open Ophthalmol. 2017; : 2
        • Stelmack JA
        • Tang XC
        • Reda DJ
        • Rinne S
        • Mancil RM
        • Massof RW
        • LOVIT Study Group
        Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT).
        Arch Ophthalmol. 2008; 126: 608-617
        • Fontenot JL
        • Bona MD
        • Kaleem MA
        • et al.
        Vision rehabilitation Preferred Practice Pattern®.
        Ophthalmology. 2018; 125 (or): P228-P278
        • Whitcher JP
        • Srinivasan M
        Corneal ulceration in the developing world–a silent epidemic.
        Br J Ophthalmol. 1997; 81: 622-623
        • Erie JC
        • Nevitt MP
        • Hodge DO
        • Ballard DJ
        Incidence of ulcerative keratitis in a defined population from 1950 through 1988.
        Arch Ophthalmol. 1993; 111: 1665-1671
        • Gonzales CA
        • Srinivasan M
        • Whitcher JP
        • Smolin G
        Incidence of corneal ulceration in Madurai district, South India.
        Ophthalmic Epidemiol. 1996; 3: 159-166
        • Liesegang TJ
        Contact lens-related microbial keratitis: Part I: Epidemiology.
        Cornea. 1997; 16: 125-131
        • Srinivasan M
        • Gonzales CA
        • George C
        • et al.
        Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India.
        Br J Ophthalmol. 1997; 81: 965-971
        • Song X
        • Xie L
        • Tan X
        • et al.
        A multi-center, cross-sectional study on the burden of infectious keratitis in China.
        PLoS One. 2014; 9e113843
        • Getshen K
        • Srinivasan M
        • Upadhyay MP
        • Priyadarsini B
        • Mahalaksmi R
        • Whitcher JP
        Corneal ulceration in South East Asia. I: a model for the prevention of bacterial ulcers at the village level in rural Bhutan.
        Br J Ophthalmol. 2006; 90: 276-278
        • Upadhyay MP
        • Srinivasan M
        • Whitcher JP
        Microbial keratitis in the developing world: does prevention work?.
        Int Ophthalmol Clin. 2007; 47: 17-25
        • Vajpayee RB
        • Ray M
        • Panda A
        • et al.
        Risk factors for pediatric presumed microbial keratitis: a case-control study.
        Cornea. 1999; 18: 565-569
        • Keay L
        • Edwards K
        • Dart J
        • Stapleton F
        Grading contact lens-related microbial keratitis: relevance to disease burden.
        Optom Vis Sci. 2008; 85: 531-537
        • Smith AF
        • Orsborn G
        Estimating the annual economic burden of illness caused by contact lens-associated corneal infiltrative events in the United States.
        Eye Contact Lens. 2012; 38: 164-170
        • Panda A
        • Ahuja R
        • Sastry SS
        Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
        Eye (Lond). 1999; 13: 744-747
        • U.S. Food and Drug Administration
        Consumer Health Information. Ensuring safe use of contact lens solution.
        www.fda.gov/ForConsumers/ConsumerUpdates/ucm164197.htm
        Date: 2009
        Date accessed: September 26, 2018
        • Centers for Disease Control and Prevention
        Healthy contact lens wear.
        www.cdc.gov/features/healthy-contact-lens/
        Date: 2016
        Date accessed: September 26, 2018
        • U.S. Food and Drug Administration
        Guidance for Industry, FDA Staff, Eye Care Professionals, and Consumers. Decorative, non-corrective contact lenses.
        • American Academy of Ophthalmology
        Eye Health. Colored contact lenses.
        www.aao.org/eye-health/glasses-contacts/colored-lenses
        Date: 2015
        Date accessed: September 26, 2018
        • Federal Trade Commission
        Contact lens rule.
        • Nilsson SE
        • Montan PG
        The annualized incidence of contact lens induced keratitis in Sweden and its relation to lens type and wear schedule: results of a 3-month prospective study.
        CLAO J. 1994; 20: 225-230
        • Bowden III, FW
        • Cohen EJ
        • Arentsen JJ
        • Laibson PR
        Patterns of lens care practices and lens product contamination in contact lens associated microbial keratitis.
        CLAO J. 1989; 15: 49-54
        • Cavanagh HD
        • Robertson DM
        • Petroll WM
        • Jester JV
        Castroviejo Lecture 2009: 40 years in search of the perfect contact lens.
        Cornea. 2010; 29: 1075-1085
        • Johnston SP
        • Sriram R
        • Qvarnstrom Y
        • et al.
        Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions.
        J Clin Microbiol. 2009; 47: 2040-2045
        • Hughes R
        • Kilvington S
        Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga.
        Antimicrob Agents Chemother. 2001; 45: 2038-2043
        • Prevention CfDCa
        Acanthamoeba keratitis associated with contact lenses–United States.
        MMWR Morb Mortal Wkly Rep. 1986; 35: 405-408
      1. !!! INVALID CITATION !!! Stapleton, 2012 #451}.

        • Hall BJ
        • Jones L
        Contact lens cases: the missing link in contact lens safety?.
        Eye Contact Lens. 2010; 36: 101-105
        • Wu YT
        • Zhu H
        • Willcox M
        • Stapleton F
        The effectiveness of various cleaning regimens and current guidelines in contact lens case biofilm removal.
        Invest Ophthalmol Vis Sci. 2011; 52: 5287-5292
        • Schachat AP
        • Oyakawa RT
        • Michels RG
        • Rice TA
        Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications.
        Ophthalmology. 1983; 90: 522-530
        • Cope JR
        • Collier SA
        • Rao MM
        • et al.
        Contact lens wearer demographics and risk behaviors for contact lens-related eye infections–United States, 2014.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 865-870
        • Mondino BJ
        • Weissman BA
        • Farb MD
        • Pettit TH
        Corneal ulcers associated with daily-wear and extended-wear contact lenses.
        Am J Ophthalmol. 1986; 102: 58-65
        • Poggio EC
        • Glynn RJ
        • Schein OD
        • et al.
        The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses.
        N Engl J Med. 1989; 321: 779-783
        • Stehr-Green JK
        • Bailey TM
        • Brandt FH
        • Carr JH
        • Bond WW
        • Visvesvara GS
        Acanthamoeba keratitis in soft contact lens wearers. A case-control study.
        JAMA. 1987; 258: 57-60
        • Stapleton F
        • Keay L
        • Edwards K
        • Holden B
        The epidemiology of microbial keratitis with silicone hydrogel contact lenses.
        Eye Contact Lens. 2013; 39: 79-85
        • Tu EY
        • Jain S
        Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
        Am J Ophthalmol. 2013; 155 (e1091.): 1095-1098